WWARN In Vitro Group

Submitting in vitro data to WWARN

The WWARN In Vitro Group strategy is to identify the most relevant drug sensitivity assays to design. 

Required for each submitted dataset:

Optional for each submitted dataset:

Unique sample or patient identifier (anonymised)

Patient age

Date of inclusion 


Basic information on study site and protocol

Genotype(s) of molecular resistance markers

Date of sample collection, sample parasitemia


Experimental protocol conditions 


In vitro raw data from each drug tested